Abstract:Abstract Background As one of the most lethal cancers, pancreatic cancer has been characterized by abundant supportive tumor-stromal cell microenvironment. Although the advent of tumor-targeted immune checkpoint blockers has brought light to patients with other cancers, its clinical efficacy in pancreatic cancer has been greatly limited due to the protective stroma. Thus, it is urgent to find potential new targets and establish multi-regulatory networks to predict patient prognosis and improve treatment. Methods We followed a strategy based on mining the Cancer Genome Atlas (TCGA) database and ESTIMATE algorithm to obtain the immune scores and stromal scores. Differentially expressed genes (DEGs) associated with poor overall survival of pancreatic cancer were screened from a TCGA cohort. By comparing global gene expression with high vs. low immune scores and subsequent Kaplan–Meier analysis, DEGs that significantly correlated with poor overall survival of pancreatic cancer in TCGA cohort were extracted. After constructing the protein–protein interaction network using STRING and limiting the genes within the above DEGs, we utilized RAID 2.0, TRRUST v2 database and degree and betweenness analysis to obtain non-coding RNA (ncRNA)-pivotal nodes and transcription factor (TF)-pivotal nodes. Finally, multi-regulatory networks have been constructed and pivotal drugs with potential benefit for pancreatic cancer patients were obtained by screening in the DrugBank. Results In this study, we obtained 246 DEGs that significantly correlated with poor overall survival of pancreatic cancer in the TCGA cohort. With the advent of 38 ncRNA-pivotal nodes and 7 TF-pivotal nodes, the multi-factor regulatory networks were constructed based on the above pivotal nodes. Prognosis-related genes and factors such as HCAR3, PPY, RFWD2, WSPAR and Amcinonide were screened and investigated. Conclusion The multi-regulatory networks constructed in this study are not only beneficial to improve treatment and evaluate patient prognosis with pancreatic cancer, but also favorable for implementing early diagnosis and personalized treatment. It is suggested that these factors may play an essential role in the progression of pancreatic cancer.

Revealing Prognosis-Related Pathways at the Individual Level by a Comprehensive Analysis of Different Cancer Transcription Data.

Pathway-Based Personalized Analysis of Pan-Cancer Transcriptomic Data

Individualized pathway activity algorithm identifies oncogenic pathways in pan-cancer analysis

A Novel Coiled-Coil Domain Containing-Related Gene Signature for Predicting Prognosis and Treatment Effect of Breast Cancer.

Identification and Functional Analysis of Individual-Specific Subpathways in Lung Adenocarcinoma

Identification of Subpathway Signatures For Ovarian Cancer Prognosis by Integrated Analyses of High-Throughput miRNA and mRNA Expression.

Integrating Single-Cell and Bulk Expression Data to Identify and Analyze Cancer Prognosis-Related Genes

Expression patterns of small numbers of transcripts from functionally-related pathways predict survival in multiple cancers

Identifying individualized risk subpathways reveals pan-cancer molecular classification based on multi-omics data

Inference of Patient-Specific Subpathway Activities Reveals a Functional Signature Associated with the Prognosis of Patients with Breast Cancer

Identification of a gene signature in cell cycle pathway for breast cancer prognosis using gene expression profiling data

Identification of Pan-Cancer Prognostic Biomarkers Through Integration of Multi-Omics Data

Identifying subpathway signatures for individualized anticancer drug response by integrating multi-omics data

Identification of Cancer Development Related Pathways Based on Co-Expression Analyses

Prognostic Gene Expression Signature Revealed the Involvement of Mutational Pathways in Cancer Genome

Identification of cell proliferation, immune response and cell migration as critical pathways in a prognostic signature for HER2+:ERα- breast cancer

Identification of Immune-Related Prognostic Biomarkers Based on the Tumor Microenvironment in 20 Malignant Tumor Types With Poor Prognosis

The Prognostic Landscape of Interactive Biological Processes Presents Treatment Responses in Cancer

Examination of Independent Prognostic Power of Gene Expressions and Histopathological Imaging Features in Cancer

Identification of prognosis-related genes and construction of multi-regulatory networks in pancreatic cancer microenvironment by bioinformatics analysis